We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Frontline Defibrillator Aids Emergency Responders

By HospiMedica International staff writers
Posted on 15 Nov 2015
An extremely compact state-of-the-art defibrillator with comprehensive monitoring functions offers highly intuitive operation. More...


The DEFIGARD Touch 7 is a new emergency combined monitor/defibrillator that is completely controlled and operated through an innovative seven-inch touch-screen display with particularly high brightness and resolution, enabling optimal display readability at all times. Thanks to projected capacitive touch technology, the display also enables highly responsive operation, even when wearing gloves. All monitoring and defibrillation functions are operated intuitively with proprietary Touch’n Save software environment.

Monitoring functions include continuous electrocardiogram (ECG) and 12-lead ECG diagnostic recording; respiration rate, measured through impedance variation when using the ECG electrodes; and blood oxygen (SPO2), carboxyhemoglobin (SPCO), an methemoglobin (SPMET) measurements are available (as an option) via Masimo Rainbow technology for rapid diagnostic and treatment of patients with carbon monoxide poisoning. Arterial blood pressure (BP) measurement, venous block, and continuous measurement of temperature are taken through skin sensors or endocavity probes.

Defibrillation functions include manual or semi-automatic modes with up to 200 Joules available at all times. In manual mode, synchronous or asynchronous defibrillation with multipulse biowave (biphasic) is delivered with high efficacy and safety, and with extremely low energy output. Pediatric electrode use is identified automatically, with energy levels adjusted accordingly. A LifePoint cardiopulmonary (CPR) feedback sensor assists in cardiac massage monitoring by displaying compression depth and rate and pressure relief at the end of each compression.

Two display modes are available; a physician mode, which presents values and waveforms as well as a manual defibrillation function, for a comprehensive overview of the patient. The second is rescue mode, where the values are displayed numerically and are well visible, even from a distance; a simple swipe gesture shifts between the two modes. High speed data transmission both during and after the intervention are available for online consultation with the regulating doctor. Depending on the location, data transmission can be performed via Wi-Fi or 3G cellular networks, with WPA2 protocols guaranteeing secure data protection.

The DEFIGARD Touch 7 was developed for use in extreme conditions, and can be operated in all land and water interventions. Thanks to its lightweight construction, it also offers new possibilities for air rescue operations, significantly saving fuel when used on an air plane or a helicopter. A further advantage is that the proprietary mounting bracket, which also serves as battery charger, works as a vibration damper, thus complying with land and air rescue operation standards.

The defibrillator is ready to use at all times, protected in a functional carrier bag where each accessory has its place, and is easily accessible and ready for immediate use as all components are connected. Regularly performed self-tests and a radiofrequency identification (RFID) transponder that monitors the defibrillator electrodes expiry date ensure immediate availability. The DEFIGARD Touch 7 Pulse is a product of Schiller (Baar, Switzerland).

Related Links:

Schiller



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.